Age and sex or gender (sex/gender) and HIV vaccine preparedness

References

• Andrasik, M. P., Yoon, R., Mooney, J., Broder, G., Bolton, M., Votto, T., … Eckstein, D. (2014). Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials. Prevention Science, 15, 268–276.10.1007/s11121-013-0371-0
   PubMed Web of Science ®Google Scholar
• Bekker, L.-G., Jaspan, H., McIntyre, J., Wood, R., & Gray, G. (2005). Adolescents and HIV vaccine trials: What are the clinical trial site issues? Journal of the International Association of Physicians in AIDS Care, 4, 93–97.10.1177/1545109705284836
   Google Scholar
• Brown-Peterside, P., Chiasson, M. A., Ren, L., & Koblin, B. A. (2000). Involving women in HIV vaccine efficacy trials: lessons learned from a vaccinepreparedness study in New York City. Journal of Urban Health, 77, 425–437.
   PubMed Web of Science ®Google Scholar
• Brown-Peterside, P., Rivera, E., Lucy, D., Slaughter, I., Ren, L., Chiasson, M.A., … Koblin BA. (2001). Retaining hard-to-reach women in HIV preventionand vaccine trials: Project ACHIEVE. American Journal of Public Health, 91, 1377–1379.
   PubMed Web of Science ®Google Scholar
• Buchbinder, S. P., Douglas, Jr. J. M., McKirnan, D. J., Judson, F. N., Katz, M. H., & MacQueen, K. M. (1996). Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate. Journal of Infectious Diseases, 174, 954–961.10.1093/infdis/174.5.954
   PubMed Web of Science ®Google Scholar
• Carneiro, M., de Figueiredo Antunes, C. M., Greco, M., Oliveira, E., Andrade, J., & Lignani, Jr. L. (2000). Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte. Journal of Acquired Immune Deficiency Syndromes, 25, 182–187.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Beyrer, C., Natpratan, C., Eiumtrakul, S., Sussman, L., Renzullo, P. O., … Nelson, K. E. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9, 1079–1083.10.1097/00002030-199509000-00015
   PubMed Web of Science ®Google Scholar
• Chu, Z., Xu, J., Reilly, K. H., Lu, C., Hu, Q., Ma, N., … Shang, H. (2013). HIV related high risk behaviors and willingness to participate in HIV vaccine trials among China MSM by computer assisted self-interviewing survey. BioMed Research International, Article ID 493128.
   Web of Science ®Google Scholar
• de Bruyn, G., Skhosana, N., Robertson, G., McIntyre, J. A., & Gray, G. E. (2008). Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Research Notes, 1, 76.10.1186/1756-0500-1-76
   PubMedGoogle Scholar
• Deschamps, M. M., Johnson, Jr. W. D., & Pape, J. P. (1994). Feasibility and cohort development for HIV vaccine trials in Haiti. AIDS Research and Human Retroviruses, 10(Suppl.2), S231–S233.
   PubMed Web of Science ®Google Scholar
• Deschamps, M. M., Zorrilla, C. D., Morgan, C. A., Donastorg, Y., Metch, B., Madenwald, T., … Pape, J. W. (2013). Recruitment of Caribbean female commercial sex workers at high risk of HIV infection. Revista Panamericana de Salud Pública, 34, 92–98.
   PubMed Web of Science ®Google Scholar
• Dhalla, S., Poole, G., Singer, J., Patrick, D. M., Wood, E., & Kerr, T. (2010). Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users. Vaccine, 28, 1663–1667.10.1016/j.vaccine.2009.12.023
   PubMed Web of Science ®Google Scholar
• Djomand, G., Metch, B., Zorrilla, C. D., Donastorg, Y., Casapia, M., Villafana, T., … Pape, J. (2008). The HVTN protocol 903 vaccine preparedness study: Lessons learned in preparation for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 48, 82–89.10.1097/QAI.0b013e31817236ab
   Google Scholar
• Etcheverry, M. F., Evans, J. L., Sanchez, E., Mendez-Arancibia, E., Meroño, M., Gatell, J. M., … Joseph J. (2013). Enhanced retention strategies andwillingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Human Vaccines &Immunotherapeutics, 9, 420–429.
   PubMed Web of Science ®Google Scholar
• Etcheverry, M. F., de Lazzari, E., Fuchs, J. D., Merono, M., Sierra, E., Del Romero, J., … Joseph, J. (2010). Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain. AIDS and Behavior, 14, 607–617.10.1007/s10461-008-9486-x
   PubMed Web of Science ®Google Scholar
• Etcheverry, M. F., Lum, P. J., Evans, J. L., Sanchez, E., de Lazzari, E., Mendez-Arancibia, E., … Joseph J. (2011). HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine, 29, 1991–1996.
   Google Scholar
• Francis, D. P., Heyward, W. L., Popovic, V., Orozco-Cronin, P., Orelind, K., Gee, C., … Berman, P. W. (2003). Candidate HIV/AIDS vaccines: Lessons learned from the world’s phase 3 efficacy trials. AIDS, 17, 147–156.10.1097/00002030-200301240-00003
   PubMed Web of Science ®Google Scholar
• Fuchs, J., Durham, M., McLellan-Lemal, E., Vittinghoff, E., Colfax, G., Gurwith, M., … Buchbinder, S. (2007). Negative social impacts among volunteers in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndromes, 46, 362–368.10.1097/QAI.0b013e3181565dcb
   PubMed Web of Science ®Google Scholar
• Geis, S., Maboko, L., Saathoff, E., Hoffmann, O., Geldmacher, C., Mmbando, D., … Hoelscher M. (2011). Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya region, Tanzania. Journal of Acquired Immune Deficiency Syndromes, 56, 453–459.10.1097/QAI.0b013e3182118fa3
   PubMed Web of Science ®Google Scholar
• Golub, E. T., Purvis, L.A., Sapun, M., Safaeian, M., Beyrer, C., Vlahov, D.,… Strathdee, S.A.(2005). Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS and Behavior, 9, 301–309.
   PubMed Web of Science ®Google Scholar
• Gray, G. E., Moodie, Z., Metch, B., Gilbert, P. B., Bekker, L. G., Churchyard, G., … HVTN 503/Phambili study team. (2014). Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: Unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infectious Diseases, 14, 388–396.10.1016/S1473-3099(14)70020-9
   PubMed Web of Science ®Google Scholar
• Gross, M., Seage, G. R., Mayer, K. A., Goldstein, R. S., Losina, E., & Wold, C. (1996). Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 406–412.10.1097/00042560-199608010-00012
   PubMedGoogle Scholar
• Hays, R. B., & Kegeles, S. M. (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 164–171.10.1097/00042560-199902010-00009
   PubMedGoogle Scholar
• Jackson, D. J., Martin, Jr. H. L., Bwayo, J. J., Nyange, P. M., Rakwar, J. P., Kashonga, F., … Kreiss, J. K. (1995). Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS, 9, 1279–1283.10.1097/00002030-199511000-00010
   PubMed Web of Science ®Google Scholar
• Jaspan, H. B., Berwick, J. R., Myer, L., Mathews, C., Flisher, A. J., Wood, R., … Bekker, L.-G. (2006). Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. Journal of Adolescent Health, 39, 642–648.10.1016/j.jadohealth.2006.05.016
   PubMed Web of Science ®Google Scholar
• Jenkins, R. A., Torugsa, K., Markowitz, L. E., Mason, C. J., Jamroentana, V., Brown, A. E., … Nitayaphan, S. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76, 386–392.10.1136/sti.76.5.386
   PubMed Web of Science ®Google Scholar
• Johnson, A. S., Hall, H. I., Hu, X., Lansky, A., Holtgrave, D. R., & Mermin, J. (2014). Trends in diagnoses of HIV infection in the United States. Journal of the American Medical Association, 312, 432–434.10.1001/jama.2014.8534
   Web of Science ®Google Scholar
• Kempf, M. C., Allen, S., Zulu, I., Kancheya, N., Stephenson, R., Brill, I., … Rwanda Zambia HIV Research Group. (2008). Enrollment and retention of HIV discordant couples in Lusaka, Zambia. Journal of Acquired Immune Deficiency Syndromes, 47, 116–125.10.1097/QAI.0b013e31815d2f3f
   PubMed Web of Science ®Google Scholar
• Kiwanuka, N., Robb, M., Kigozi, G., Birx, D., Philips, J., Wabwire-Mangen, F., … Gray, R. H. (2004). Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: A population-based study, Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, 36, 721–725.10.1097/00126334-200406010-00009
   PubMed Web of Science ®Google Scholar
• Kiwanuka, N., Ssetaala, A., Mpendo, J., Wambuzi, M., Nanvubya, A., Sigirenda, S., … Sewankambo, N. K. (2013). High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. Journal of the International AIDS Society, 16, 1–7.
   PubMed Web of Science ®Google Scholar
• Koblin, B. A., Avrett, S., Taylor, P. E., & Stevens, C. E. (1997). Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 165–171.10.1097/00042560-199706010-00011
   PubMedGoogle Scholar
• Koblin, B. A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J. M., … Seage G. (1998). Readiness of high-risk populations in the HIV network for prevention trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12, 785–793.10.1097/00002030-199807000-00015
   PubMed Web of Science ®Google Scholar
• Koblin, B. A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV vaccine trials: changes in willingness and knowledge among highriskpopulations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. Journal of Acquired ImmuneDeficiency Syndromes, 24, 451–457.
   PubMed Web of Science ®Google Scholar
• Koblin, B. A., Mayer, K. H., Eshleman, S. H., Wang, L., Mannheimer, S., del Rio, C., … HPTN 061 Protocol Team. (2013). Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV Prevention Trials Network (HPTN) 061. PLoS ONE, 8, e70413.
   PubMed Web of Science ®Google Scholar
• Koblin, B. A., Taylor, P. E., Avrett, S., & Stevens, C. E. (1996). The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS, 10, 1555–1561.10.1097/00002030-199611000-00015
   PubMed Web of Science ®Google Scholar
• Li, Q., Luo, F., Zhou, Z., Li, S., Liu, Y., Li, D., … Shao, Y. (2010). Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men. Vaccine, 28, 4638–4643.10.1016/j.vaccine.2010.04.073
   PubMed Web of Science ®Google Scholar
• Ma, M., Toni Young, A., Durham, M., Kibler, J. L., Gaul, Z., Pals, S., … Sutton, M. Y. (2014). Predictors of willingness of participate in HIV vaccine trials among African Americans. Journal of AIDS & Clinical Research, 5, 361.
   Google Scholar
• Markowitz, L. E., Sirisopana, N., Charonwatanachokchai, A., Julvanichpong, W., Siraprapasiri, T., Palanuvej, T., … Brown, A. E. (1999). Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 488–494.10.1097/00042560-199904150-00012
   PubMedGoogle Scholar
• Marmor, M., Titus, S., Wolfe, H., Krasinski, K., Maslansky, R., Simberkoff, M., … Des Jarlais DC. (1994). Retention, behavior change and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Research and Human Retroviruses, 110, S207–S213.
   Google Scholar
• McGrath, J. W., George, K., Svilar, G., Ihler, E., Mafigiri, D., & Kabugo, M. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27, 381–388.10.1097/00126334-200108010-00009
   PubMed Web of Science ®Google Scholar
• Metch, B., Frank, I., Novak, R., Swann, E., Metzger, D., Morgan, C., … Koblin B.(2013). Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials. AIDS and Behavior, 17, 760–772.
   PubMed Web of Science ®Google Scholar
• Meque, I., Dubé, K., Bierhuizen, L., Zango, A., Veldhuijzen, N., Cumbe, F., & van de Wijgert, J. (2014). Willingness to participate in future HIV prevention trials in Beira, Mozambique. African Journal of AIDS Research, 13, 393–398.10.2989/16085906.2014.985239
   PubMed Web of Science ®Google Scholar
• Meyers, K., David, S., Metzger, D. S., Navaline, H., Woody, G. E., & McLellan, T. (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84, 761–766.10.2105/AJPH.84.5.761
   PubMed Web of Science ®Google Scholar
• Middelkoop, K., Myer, L., Mark, D., Mthimunye, D. P., Smit, J., Wood, R., … Bekker, L.-G. (2008). Journal of Adolescent Health, 43, 8–14.10.1016/j.jadohealth.2007.11.144
   PubMed Web of Science ®Google Scholar
• Mills, E. J., Nixon, S., Singh, S., Dolma, S., Nayyar, A., & Kapoor, S. (2006). Enrolling women into HIV preventive vaccine trials: An ethical imperative but a logistical challenge. PLoS Medicine, 3, e94.
   PubMed Web of Science ®Google Scholar
• Natpratan, C., Nantakwang, D., Beyrer, C., Kunawararak, P., Gunhom, C., Celentano, D. D., … Khamboonruang, C. (1996). Feasibility of northern Thai factory workers as participants in HIV vaccine trials. Southeast Asian Journal of Tropical Medicine and Public Health, 27, 457–462.
   PubMedGoogle Scholar
• Newman, P. A., Chakrapani, V., Weaver, J., Shunmugam, M., & Rubincam, C. (2014). Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India. Vaccine, 32, 5854–5861.10.1016/j.vaccine.2014.08.043
   PubMed Web of Science ®Google Scholar
• Olanrewaju, O., Onigbogi, M. O., & Omobola, O. (2014). Willingness to participate (WTP) in HIV vaccine trials among itinerant female hairdressers in Ibadan, Nigeria. Journal of AIDS and Clinical Research, 5, 325.
   Google Scholar
• Otwombe, K. N., Sikkema, K. J., Dietrich, J., de Bruyn, G., van derWatt, M., & Gray, G. E. (2011). Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: A survey conducted among adolescents in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndromes, 58, 211–218.10.1097/QAI.0b013e31822b7702
   PubMed Web of Science ®Google Scholar
• Périssé, A.R., Schechter, M., Moreira, R. I., do Lago, R. F., Santoro-Lopes, G., & Harrison, L. H. (2000). Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 25, 459–463.10.1097/00126334-200012150-00012
   PubMed Web of Science ®Google Scholar
• Pitisuttithum, P., Choopanya, K., Bussaratid, V., Vanichseni, S., Van Griensven, F., Phonrat, B., … Francis, D. (2007). Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand. Journal of the Medical Association of Thailand, 90, 2442–2448.
   PubMedGoogle Scholar
• Price, M. A., Rida, W., Mwangome, M., Middelkoop, K., Roux, S., Okuku, H. S., & Sanders, E. J. (2012). Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report xex with men, sex workers, and youth. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 59, 185–193.10.1097/QAI.0b013e31823d8693
   Google Scholar
• Ruzagira, E., Wandiembe, S., Bufumbo, L., Levin, J., Price, M. A., Grosskurth, H., … Kamali, A. (2009). Willingness to participate in preventive HIV vaccine trials in a community based cohort in south western Uganda. Tropical Medicine & International Health, 14, 196–203.
   PubMed Web of Science ®Google Scholar
• Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K., … Paranjape, R. (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23, 1351–1358.10.1016/j.vaccine.2004.09.032
   PubMed Web of Science ®Google Scholar
• Scheer, S., Douglas, J. M., Vittinghoff, E., Bartholow, B. N., McKirnan, D., Judson, F. N., … Buchbinder, S. (1999). Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20, 172–178.10.1097/00042560-199902010-00010
   PubMedGoogle Scholar
• Seage, G. R. 3rd, Holte, S. E., Metzger, D., Koblin, B. A., Gross, M., Celum, C., … Buchbinder, S. P. (2001). Are US populations appropriate for trials ofhuman immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. American Journal of Epidemiology, 153, 619–627.
   PubMed Web of Science ®Google Scholar
• Starace, F., Wagner, T. M., Luzi, A. M., Cafaro, L., Gallo, P., & Rezza, G. (2006). Knowledge and attitudes regarding preventive HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care, 18, 66–72.10.1080/09540120500161777
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Hogg, R. S., Cornelisse, P. G., Martindale, S. L., Currie, S. L., O’Shaugnessy, M. V., … Schechter, M. T. (2000). Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men. AIDS and Behavior, 4, 271–278.10.1023/A:1009520802874
   Google Scholar
• Suhadev, M., Nyamathi, A. M., Swaminathan, S., Suresh, A., & Venkatesan, P. (2009). Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Research and Human Retroviruses, 25, 217–224.10.1089/aid.2007.0312
   PubMed Web of Science ®Google Scholar
• Tello, J., Soong, S., Hunter, B., Meriwether, R., HOOK, E.W., & Mulligan, M. J. (1998). HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic. American Journal of the Medical Sciences, 315, 11–16.10.1097/00000441-199801000-00003
   PubMed Web of Science ®Google Scholar
• Van de Ven, P., Mao, L., Crawford, J., Prestage, G., Grulich, A., Kaldor, J., … Kippax S. (2005). Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. International Journal of STD and AIDS, 16, 314–317.10.1258/0956462053654212
   PubMed Web of Science ®Google Scholar
• Volk, J. E., Hessol, N. A., Gray, G. E., Kublin, J. G., Churchyard, G. J., Mlisana, K., … Bekker, L.-G. (2014). The HVTN503/Phambili HIV vaccine trial: A comparison of younger and older participants. International Journal of STD and AIDS, 25, 332–340.10.1177/0956462413506892
   PubMed Web of Science ®Google Scholar
• Woody, G.E., Metzger, D., & Mulvaney, F. Preparations for AIDS vaccine trials. (1994). Recruitment and retention of in- and out-of-treatment injection drug users. AIDS Research and Human Retroviruses, 10( Suppl 2), S197–199.
   PubMed Web of Science ®Google Scholar
• Yin, L., Zhang, Y., Qian, H. Z., Rui, B., Zhang, L., Zhu, J., … Shao Y. (2008). Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine, 26, 762–768.10.1016/j.vaccine.2007.11.091
   PubMed Web of Science ®Google Scholar